Mystery Case: A 63-year-old man with progressive proximal pain and weakness

Neurology

Volumn 82, Issue 4, 2014, Pages

  Scripko, Patricia D ^a   Amato, Anthony A ^c   Puig, Alberto ^b,d  

^a Department of Neurology ^*  (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CREATINE KINASE; IMMUNOGLOBULIN G; JO 1 ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; PLASMA PROTEIN; PREDNISONE; SIMVASTATIN;

ACHILLES REFLEX; ADULT; ARTICLE; CANCER SCREENING; CASE REPORT; CERVICOBRACHIAL NEURALGIA; CLIMBING; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DIPLOPIA; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSPNEA; EATON LAMBERT SYNDROME; ELECTROMYOGRAM; ELECTROPHORESIS; ERYTHROCYTE SEDIMENTATION RATE; HIP PAIN; HUMAN; HYPERSALIVATION; IMMUNE MEDIATED NECROTIZING MYOPATHY; IMMUNOPATHOLOGY; INFLAMMATORY INFILTRATE; KNEE FUNCTION; MALE; MIDDLE AGED; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE FIBER MEMBRANE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASPINAL MUSCLE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RHEUMATOLOGY; SARCOLEMMA; SHOULDER PAIN; SPEECH; TOXIC MYOPATHY; WEIGHT REDUCTION;

BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CREATINE KINASE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ELECTROMYOGRAPHY; FATIGUE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NEUROMUSCULAR JUNCTION DISEASES; PAIN; PYRROLES; SHOULDER PAIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85047687168     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000052     Document Type: Article

References (7)

1. Benveniste O, Drouot L, Jouen F, et al. Correlation of antisignal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum 2011;63:1961-1971.
2. Emslie-Smith AM, Engel AG. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration. Neurology 1991;41:936-939.
3. LevinMI, Mozaffar T, Al-LoziMT, Pestronk A. Paraneoplastic necrotizing myopathy: Clinical and pathological features. Neurology 1998;50:764-767.
4. Grable-Esposito P, Katzberg HD, Greenberg SA, et al. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve 2010;41:185-190.
5. Needham M, Fabian V, Knezevic W, et al. Progressive myopathy with upregulation of MHC-I associated with statin therapy. Neuromuscul Disord 2007;17:194-200.
6. Mammen AL, Chung T, Christopher-Stine L, et al, Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713-721.
7. Mammen AL, Pak K, Williams EK, et al. Rarity of anti-3-hydroxy-3- methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res 2012;64:269-272.